{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:28:37Z","timestamp":1791581317321,"version":"4.3.4"},"reference-count":44,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T00:00:00Z","timestamp":1624060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>As part of a national surveillance programme initiated in 2004, fungal blood isolates from 2016\u20132018 underwent species identification and EUCAST susceptibility testing. The epidemiology was described and compared to data from previous years. In 2016\u20132018, 1454 unique isolates were included. The fungaemia rate was 8.13\/100,000 inhabitants compared to 8.64, 9.03, and 8.38 in 2004\u20132007, 2008\u20132011, and 2012\u20132015, respectively. Half of the cases (52.8%) involved patients 60\u201379 years old and the incidence was highest in males \u226570 years old. Candida albicans accounted for 42.1% of all isolates and Candida glabrata for 32.1%. C. albicans was more frequent in males (p = 0.03) and C. glabrata in females (p = 0.03). During the four periods, the proportion of C. albicans decreased (p &lt; 0.001), and C. glabrata increased (p &lt; 0.001). Consequently, fluconazole susceptibility gradually decreased from 68.5% to 59.0% (p &lt; 0.001). Acquired fluconazole resistance was found in 4.6% Candida isolates in 2016\u20132018. Acquired echinocandin resistance increased during the four periods 0.0%, 0.6%, 1.7% to 1.5% (p &lt; 0.0001). Sixteen echinocandin-resistant isolates from 2016\u20132018 harboured well-known FKS resistance-mutations and one echinocandin-resistant C. albicans had an FKS mutation outside the hotspot (P1354P\/S) of unknown importance. In C. glabrata specifically, echinocandin resistance was detected in 12\/460 (2.6%) in 2016\u20132018 whereas multidrug-class resistance was rare (1\/460 isolates (0.2%)). Since the increase in incidence during 2004\u20132011, the incidence has stabilised. In contrast, the species distribution has changed gradually over the 15 years, with increased C. glabrata at the expense of C. albicans. The consequent decreased fluconazole susceptibility and the emergence of acquired echinocandin resistance complicates the management of fungaemia and calls for antifungal drug development.<\/jats:p>","DOI":"10.3390\/jof7060491","type":"journal-article","created":{"date-parts":[[2021,6,20]],"date-time":"2021-06-20T22:00:02Z","timestamp":1624226402000},"page":"491","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Update 2016\u20132018 of the Nationwide Danish Fungaemia Surveillance Study: Epidemiologic Changes in a 15-Year Perspective"],"prefix":"10.3390","volume":"7","author":[{"given":"Malene","family":"Risum","sequence":"first","affiliation":[{"name":"Unit of Mycology, Statens Serum Institut, 2300 K\u00f8benhavn, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Astvad","sequence":"additional","affiliation":[{"name":"Unit of Mycology, Statens Serum Institut, 2300 K\u00f8benhavn, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle Krogh","family":"Johansen","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, University Hospital of Copenhagen, Rigshospitalet, 2100 K\u00f8benhavn, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen, 1165 K\u00f8benhavn, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik Carl","family":"Sch\u00f8nheyder","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Aalborg University Hospital, 9100 Aalborg, Denmark"},{"name":"Department of Clinical Medicine, Aalborg University, 9220 Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2129-328X","authenticated-orcid":false,"given":"Flemming","family":"Rosenvinge","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Odense University Hospital, 5000 Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8699-9956","authenticated-orcid":false,"given":"Jenny Dahl","family":"Knudsen","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, University Hospital of Copenhagen, Rigshospitalet, 2100 K\u00f8benhavn, Denmark"},{"name":"Department of Clinical Microbiology, Hvidovre Hospital, 2650 Hvidovre, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9796-023X","authenticated-orcid":false,"given":"Rasmus Kr\u00f8ger","family":"Hare","sequence":"additional","affiliation":[{"name":"Unit of Mycology, Statens Serum Institut, 2300 K\u00f8benhavn, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raluca","family":"Datcu","sequence":"additional","affiliation":[{"name":"Unit of Mycology, Statens Serum Institut, 2300 K\u00f8benhavn, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bent L\u00f8we","family":"R\u00f8der","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Slagelse Sygehus, 4200 Slagelse, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria Stanislavovna","family":"Antsupova","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Herlev and Gentofte Hospital, 2730 Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Kristensen","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Aarhus University Hospital, 8200 Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Berg","family":"Gertsen","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Aarhus University Hospital, 8200 Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Kj\u00f8lseth","family":"M\u00f8ller","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Vejle Sygehus, University Hospital of Southern Denmark, 7100 Vejle, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esad","family":"Dzajic","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Sydvestjysk Sygehus, 6700 Esbjerg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turid Snekloth","family":"S\u00f8ndergaard","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Sygehus S\u00f8nderjylland, 6400 S\u00f8nderborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4747-0144","authenticated-orcid":false,"given":"Maiken Cavling","family":"Arendrup","sequence":"additional","affiliation":[{"name":"Unit of Mycology, Statens Serum Institut, 2300 K\u00f8benhavn, Denmark"},{"name":"Department of Clinical Microbiology, University Hospital of Copenhagen, Rigshospitalet, 2100 K\u00f8benhavn, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen, 1165 K\u00f8benhavn, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMra1315399","article-title":"Invasive Candidiasis","volume":"373","author":"Kullberg","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijid.2018.08.010","article-title":"High incidence of candidaemia in a nationwide cohort: Underlying diseases, risk factors and mortality","volume":"76","author":"Lausch","year":"2018","journal-title":"Int. J. Infect. Dis."},{"key":"ref_3","unstructured":"(2016). Behandlingsvejledning Inklusiv L\u00e6gemiddelrekommandation for Systemisk Antimykotisk Behandling, R\u00e5det Anvendelse af Dyr Sygehusmedicin. version 2."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID guideline for the diagnosis and management of Candida diseases 2012: Non-neutropenic adult patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1469-0691.2008.01954.x","article-title":"Semi-national surveillance of fungaemia in Denmark 2004-2006: Increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility","volume":"14","author":"Arendrup","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1128\/JCM.43.9.4434-4440.2005","article-title":"Seminational surveillance of fungemia in Denmark: Notably high rates of fungemia and numbers of isolates with reduced azole susceptibility","volume":"43","author":"Arendrup","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1128\/JCM.00179-11","article-title":"Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia","volume":"49","author":"Arendrup","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"E343","DOI":"10.1111\/1469-0691.12212","article-title":"Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: Data from a nationwide fungaemia surveillance programme","volume":"19","author":"Arendrup","year":"2013","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e01564-17","DOI":"10.1128\/JCM.01564-17","article-title":"Update from a 12-year nationwide fungemia surveillance: Increasing intrinsic and acquired resistance causes concern","volume":"56","author":"Astvad","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/QCO.0000000000000111","article-title":"Echinocandin resistance: An emerging clinical problem?","volume":"27","author":"Arendrup","year":"2014","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cmi.2019.03.028","article-title":"Resistance of Candida to azoles and echinocandins worldwide","volume":"25","author":"Pristov","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/nyas.12831","article-title":"Mechanisms of echinocandin antifungal drug resistance","volume":"1354","author":"Perlin","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.cmi.2015.06.008","article-title":"Twenty-two years of candidaemia surveillance: Results from a Norwegian national study","volume":"21","author":"Hesstvedt","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1128\/JCM.00029-06","article-title":"Candidemia in Norway (1991 to 2003): Results from a nationwide study","volume":"44","author":"Sandven","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1128\/JCM.02566-12","article-title":"Nationwide study of candidemia, antifungal use, and antifungal drug resistance in Iceland, 2000 to 2011","volume":"51","author":"Asmundsdottir","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/myc.12816","article-title":"Epidemiology of fungaemia in Sweden: A nationwide retrospective observational survey","volume":"61","author":"Klingspor","year":"2018","journal-title":"Mycoses"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"E218","DOI":"10.1111\/1469-0691.12111","article-title":"Candidaemia in Sweden: A nationwide prospective observational survey","volume":"19","author":"Ericsson","year":"2013","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/myc.12535","article-title":"Differences in epidemiology of candidaemia in the Nordic countries\u2014what is to blame?","volume":"60","author":"Hesstvedt","year":"2017","journal-title":"Mycoses"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/CCM.0000000000000746","article-title":"Invasive Candida infections and the harm from antibacterial drugs in critically ill patients: Data from a randomized, controlled trial to determine the role of ciprofloxacin, piperacillin-tazobactam, meropenem, and cefuroxime","volume":"43","author":"Jensen","year":"2015","journal-title":"Crit. Care Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1128\/JCM.00263-17","article-title":"Validation of a new web application for identification of fungi by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry","volume":"55","author":"Normand","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1128\/JCM.01811-10","article-title":"National Surveillance of Fungemia in Denmark (2004 to 2009)","volume":"49","author":"Arendrup","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"E246","DOI":"10.1111\/j.1469-0691.2012.03880.x","article-title":"EUCAST technical note on the EUCAST definitive document EDef 7.2: Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)*","volume":"18","author":"Arendrup","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.cmi.2020.06.007","article-title":"How to: Interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST)","volume":"26","author":"Arendrup","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/13693780801968571","article-title":"Candida lusitaniae fungemia in cancer patients: Risk factors for amphotericin B failure and outcome","volume":"46","author":"Atkinson","year":"2008","journal-title":"Med. Mycol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1469-0691.2006.01377.x","article-title":"Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values","volume":"12","author":"Turnidge","year":"2006","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_27","unstructured":"(2021, May 25). European Committee on Antimicrobial Susceptibility Testing. Overview of Antifungal ECOFFs and Clinical Breakpoints for Yeasts, Moulds and Dermatophytes Using the European Committee on Antimicrobial Susceptibility Testing Overview of Antifungal ECOFFs and Clinical Breakpoints for Yeasts, Moulds and Overv Antifung ECOFFs Clin Break Yeasts, Mould Dermatophytes Using EUCAST E.Def 7.3, E.Def 9.3 E.Def 11.0 procedures. Version 2. Available online: http:\/\/www.eucast.org."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6808a1","article-title":"Population-Based Active Surveillance for Culture-Confirmed Candidemia\u2014Four Sites, United States, 2012\u20132016","volume":"68","author":"Toda","year":"2019","journal-title":"MMWR Surveill. Summ."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Santolaya, M.E., Thompson, L., Benadof, D., Tapia, C., Legarraga, P., Cort\u00e9s, C., Rabello, M., Valenzuela, R., Rojas, P., and Rabagliati, R. (2019). A prospective, multi-center study of candida bloodstream infections in Chile. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0212924"},{"key":"ref_30","first-page":"e449","article-title":"Burden of Candidemia in the United States, 2017","volume":"71","author":"Tsay","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1093\/cid\/ciz1061","article-title":"The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Increasingly Common Risk Factor\u2014Active Surveillance in Selected Sites, United States, 2014\u20132017","volume":"71","author":"Zhang","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Doi, A.M., Pignatari, A.C.C., Edmond, M.B., Marra, A.R., Camargo, L.F.A., Siqueira, R.A., da Mota, V.P., and Colombo, A.L. (2016). Epidemiology and Microbiologic Characterization of Nosocomial Candidemia from a Brazilian National Surveillance Program. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0146909"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1080\/23744235.2019.1662941","article-title":"Clinical and microbiological factors associated with mortality in candidemia in adult patients 2007\u20132016","volume":"51","author":"Valkonen","year":"2019","journal-title":"Infect. Dis."},{"key":"ref_34","unstructured":"Public Health England (2019). Laboratory surveillance of candidaemia in England, Wales and Northern Ireland: 2018. Health Prot. Rep., 9, 13."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/23744235.2019.1595709","article-title":"The impact of age on risk assessment, therapeutic practice and outcome in candidemia","volume":"51","author":"Hesstvedt","year":"2019","journal-title":"Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/myc.13050","article-title":"Changing epidemiology of candidaemia: Increase in fluconazole-resistant Candida parapsilosis","volume":"63","author":"Mesini","year":"2020","journal-title":"Mycoses"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/1120009X.2020.1783154","article-title":"Species distribution and antifungal susceptibilities of bloodstream Candida isolates: A nine-years single center survey","volume":"32","author":"Brescini","year":"2020","journal-title":"J. Chemother."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s15010-015-0845-z","article-title":"Epidemiology, clinical characteristics, and outcome of candidemia in a tertiary referral center in Italy from 2010 to 2014","volume":"44","author":"Barchiesi","year":"2016","journal-title":"Infection"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/myc.12714","article-title":"Increasing candidaemia incidence from 2004 to 2015 with a shift in epidemiology in patients preexposed to antifungals","volume":"61","author":"Goemaere","year":"2018","journal-title":"Mycoses"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e13655","DOI":"10.1111\/ijcp.13655","article-title":"Epidemiology, risk factors, treatment and outcome of Candida bloodstream infections because of Candida albicans and Candida non-albicans in two district general hospitals in the United Kingdom","volume":"75","author":"Raja","year":"2021","journal-title":"Int. J. Clin. Pract."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/mmy\/myx165","article-title":"The epidemiology and management of candidemia in Northern Ireland during 2002-2011, including a 12-month enhanced case review","volume":"57","author":"Spiers","year":"2019","journal-title":"Med. Mycol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jiac.2019.01.002","article-title":"Mortality and risk factor analysis for Candida blood stream infection: A multicenter study","volume":"25","author":"Kato","year":"2019","journal-title":"J. Infect. Chemother."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/INF.0000000000002207","article-title":"Pediatric Candidemia Epidemiology and Morbidities: A nationwide cohort","volume":"38","author":"Lausch","year":"2019","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/INF.0000000000002530","article-title":"Etiology and Outcome of Candidemia in Neonates and Children in Europe: An 11-year Multinational Retrospective Study","volume":"39","author":"Warris","year":"2020","journal-title":"Pediatr. Infect. Dis. J."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/7\/6\/491\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:19:12Z","timestamp":1760163552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/7\/6\/491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,19]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["jof7060491"],"URL":"https:\/\/doi.org\/10.3390\/jof7060491","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,19]]}}}